Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation.

Debald M, Pölcher M, Flucke U, Walgenbach-Brünagel G, Walgenbach KJ, Höller T, Wolfgarten M, Rudlowski C, Büttner R, Schild H, Kuhn W, Braun M.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1128-33. doi: 10.1016/j.ijrobp.2009.06.088. Epub 2010 Feb 3.

PMID:
20133078
2.

Podoplanin expression in basal and myoepithelial cells: utility and potential pitfalls.

Kanner WA, Galgano MT, Atkins KA.

Appl Immunohistochem Mol Morphol. 2010 May;18(3):226-30. doi: 10.1097/PAI.0b013e3181c65141.

PMID:
20042851
3.

D2-40 immunohistochemistry--so far!

Kalof AN, Cooper K.

Adv Anat Pathol. 2009 Jan;16(1):62-4. doi: 10.1097/PAP.0b013e3181915e94. Review.

PMID:
19098468
4.

D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.

Rabban JT, Chen YY.

Hum Pathol. 2008 Feb;39(2):175-83. doi: 10.1016/j.humpath.2007.06.018.

PMID:
18206495
5.

Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.

Braun M, Flucke U, Debald M, Walgenbach-Bruenagel G, Walgenbach KJ, Höller T, Pölcher M, Wolfgarten M, Sauerwald A, Keyver-Paik M, Kühr M, Büttner R, Kuhn W.

Breast Cancer Res Treat. 2008 Dec;112(3):503-11. doi: 10.1007/s10549-007-9875-2. Epub 2007 Dec 29.

PMID:
18165897
6.

Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.

Acs G, Dumoff KL, Solin LJ, Pasha T, Xu X, Zhang PJ.

Am J Surg Pathol. 2007 Jan;31(1):129-40.

PMID:
17197929
7.

Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.

de Araújo VC, Altemani A, Furuse C, Martins MT, de Araújo NS.

Oral Oncol. 2006 Nov;42(10):1011-6. Epub 2006 Jun 6.

PMID:
16757205
8.
9.

Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma.

Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ.

Mod Pathol. 2005 Jan;18(1):105-10.

10.

Current practical applications of diagnostic immunohistochemistry in breast pathology.

Lerwill MF.

Am J Surg Pathol. 2004 Aug;28(8):1076-91. Review.

PMID:
15252316
11.
12.

Immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in breast carcinoma.

El-Zammar OA, Haidar A.

Ann Diagn Pathol. 2003 Oct;7(5):335. No abstract available.

PMID:
14571439
13.
14.

A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors.

Kahn HJ, Marks A.

Lab Invest. 2002 Sep;82(9):1255-7. No abstract available.

PMID:
12218087
16.

Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.

Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T.

Mod Pathol. 2002 Apr;15(4):397-405.

17.

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR.

Br J Cancer. 2001 Aug 3;85(3):422-7.

18.

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.

Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C.

Am J Surg Pathol. 2001 Aug;25(8):1054-60.

PMID:
11474290
19.

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.

Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D.

Am J Pathol. 1999 Feb;154(2):385-94.

Supplemental Content

Support Center